New 6-year data from the ACAPELLA study, a real-world analysis of patients with multiple sclerosis (MS) on ocrelizumab (Ocrevus; Genentech), showed a higher rate of severe infection in treated patients aged 55... Read more »
During the coronavirus pandemic in 2020, SeraCollection Research Services in Montebello redirected its research to focus on COVID-19 and used its resources to help mitigate the pandemic and serve underserved communities. “Immediately... Read more »